Unfortunately, a woman’s organism produces only 4-5 grams of lactoferrin per liter of milk, besides, donor milk can be infected by HIV or other dangerous viruses. So, it is impossible to fully rely on female donor milk. As the researchers failed to get lactoferrin with the help of transgenic microorganisms (the main manner of production of multiple protein drugs), there is an opportunity to make a transgenic animal which produces human lactoferrin with its own milk.
“The idea of getting lactoferrin from the milk of transgenic animals awoke our interest about ten years ago. We started our experiments with genetic construction, made great progress, after which we received transgenic mice. As a result of lengthy and laborious efforts with more than 5,000 transgenic mice, it was ascertained that the transgene was inherited by posterity, and the lactoferrin concentration is several times higher than that in the feminine breast milk. The “record-holder” mice produced up to 40 grams of human lactoferrin per liter of their milk. At that, human lactoferrin obtained from the mouse milk has turned out to be absolutely identical to the natural protein of feminine milk. Drugs and medical cosmetics based on human lactoferrin will be developed jointly with colleagues from other organizations,” says the initiator of the work I.L. Goldman, Director of Transgenebank, Institute of Biology of Gene, Russian Academy of Sciences.
Human lactoferrin industrial production is planned to be based on transgenic she-goats. A good she-goat produces as much milk as a bad cow – 1,000 liters per lactation. That is why successful efforts on creation of transgenic goats are being undertaken all over the world, their milk containing certain useful proteins. “Experiments on she-goats are limited by three circumstances: the goat is a seasonal animal in terms of the type of reproduction, the pregnancy period lasts for almost half a year. Besides, dairy goat-faming in Russia and Belarus is absent as a stock-raising branch,” says E.R.Sadchikova, Head of Transgenosis Laboratory, Institute of Biology of Gene, Russian Academy of Sciences.
The researchers from the Institute of Biology of Gene, Russian Academy of Sciences, have for the long time strived to obtain funding of this work from the Government of the Russian Federation, however, they failed. Instead, they have managed to establish a special BelRosTransgene program of the Federal State of Russia and Belarus. In 2003, the Biotechnological Center was set up in the scope of this program at the farm of the Scientific and Practical Center of the National Academy of Sciences for stock-raising in the town of Zhodino. Within four years of operation, the Belarus and Russian researchers jointly carried out a large number of experiments on creation of transgenic she-goats via “implantation” of the human lactoferrin gene into them. In the beginning, a lot of failures occurred. Finally, in late autumn of 2007, first transgenic kids were born at the biotechnological farm in the town of Zhodino, the lids were called Luck 1 and Luck 2.
“Unfortunately, since January 1, 2007, when the term of BelRosTransgene program funding expired, the Scientific and Practical Center for stock-raising of the National Academy of Sciences of Belarus had to undertake further financing of work to support the goat flock. It is assumed that when he-goats come into the “virile strength”, the first posterity will be received from them,” says Alexander Budevich, head of laboratory of the Center.
Now, the researchers are preparing a new BelRosTransgene-2 program of the Federal State of Russia and Belarus to ensure financial support for the work in the next ten years. The goats should be fed, kept warm, guarded, and the lactoferrin drugs should be developed and tested, their patents should be protected. Only after these obstacles have been overcome, it can be assumed that she-goats, which provide milk with the unique human protein, will be able to start earning their living, and that the next break-through of the native science will also turn out to be the break-through in high-technologies business of the 21st century.
Nadezda Markina | alfa
A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich
New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
17.02.2017 | Medical Engineering
17.02.2017 | Medical Engineering
17.02.2017 | Health and Medicine